I reckon if the rapid testing business goes well (and for the next 2-3 yrs if tech works no reason it wouldn’t go well) it’s worth 1.5-2$ per share, which is call it $600-800m mcap (I mean look at ADO as nearest comp). Add on that the track and trace and anti counter, PPE etc we could have here conservatively 3-4$ per share. I think once company has established validation of the tech via few initial sales we should have a very strong re rating.
Dotz Nano Vs Covid 19, page-222
-
- There are more pages in this discussion • 294 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DTZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $68.08M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.0¢ | 12.5¢ | $2.453K | 19.25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 200000 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 29045 | 1 |
View Market Depth
| Last trade - 16.10pm 22/07/2024 (20 minute delay) ? |
| DTZ (ASX) Chart |